Creative Biomolecules, Inc.
Records under this name other than patents Creative Biomolecules, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Creative Biomolecules, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,060,903 | Signal processing apparatus and methods Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 6,632,618 | Morphogenic protein-specific cell surface receptors and uses therefor Formerly held Term ended Term ended Oct 14, 2020 · From the USPTO record | Term ended | Term ended Oct 14, 2020 | From the USPTO record |
| US 6,495,513 | Morphogen-enhanced survival and repair of neural cells Formerly held Term ended Term ended Dec 17, 2019 · From the USPTO record | Term ended | Term ended Dec 17, 2019 | From the USPTO record |
| US 6,686,388 | Regulators of the hedgehog pathway, compositions and uses related thereto Formerly held Term ended Ended no later than Oct 14, 2019 · From the USPTO record | Term ended | Ended no later than Oct 14, 2019 | From the USPTO record |
| US 6,677,432 | Mutations of the C-terminal portion of TGF-&bgr; superfamily proteins Formerly held Term ended Term ended Aug 16, 2019 · From the USPTO record | Term ended | Term ended Aug 16, 2019 | From the USPTO record |
| US 6,399,569 | Morphogen treatments for limiting proliferation of epithelial cells Formerly held Term ended Ended no later than Jun 4, 2019 · From the USPTO record | Term ended | Ended no later than Jun 4, 2019 | From the USPTO record |
| US 6,897,297 | Hydrophobically-modified protein compositions and methods Formerly held Term ended Term ended Dec 13, 2018 · From the USPTO record | Term ended | Term ended Dec 13, 2018 | From the USPTO record |
| US 6,444,793 | Hydrophobically-modified hedgehog protein compositions and methods Formerly held Term ended Term ended Dec 3, 2018 · From the USPTO record | Term ended | Term ended Dec 3, 2018 | From the USPTO record |
| US 6,333,312 | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases Formerly held Term ended Term ended Oct 13, 2018 · From the USPTO record | Term ended | Term ended Oct 13, 2018 | From the USPTO record |
| US 6,013,856 | Terminally sterilized osteogenic devices and preparation thereof Formerly held Term ended Term ended Sep 23, 2018 · From the USPTO record | Term ended | Term ended Sep 23, 2018 | From the USPTO record |